000 01283 a2200373 4500
005 20250514234654.0
264 0 _c20060113
008 200601s 0 0 eng d
022 _a0920-9964
024 7 _a10.1016/j.schres.2005.06.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFleischhacker, W Wolfgang
245 0 0 _aThe European First Episode Schizophrenia Trial (EUFEST): rationale and design of the trial.
_h[electronic resource]
260 _bSchizophrenia research
_cOct 2005
300 _a147-56 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xpharmacokinetics
650 0 4 _aBrain
_xmetabolism
650 0 4 _aEurope
650 0 4 _aFollow-Up Studies
650 0 4 _aHospitalization
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aPrevalence
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
700 1 _aKeet, Ireneus P M
700 1 _aKahn, René S
773 0 _tSchizophrenia research
_gvol. 78
_gno. 2-3
_gp. 147-56
856 4 0 _uhttps://doi.org/10.1016/j.schres.2005.06.004
_zAvailable from publisher's website
999 _c15708462
_d15708462